ArticleCell discovery2015

Enhancement of the in vivo persistence and antitumor efficacy of CD19 chimeric antigen receptor T cells through the delivery of modified TERT mRNA.

Yun Bai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.